In Media
BioWorld – September 2024
Stimvia receives MDR certification for neuromodulation system
Med-Tech Innovation – August 2024
Stimvia plans to enter neuromodulation market in the USA after MDR certification
BioSpace magazine – June 2024
Potential Add-on Treatment for Patients with Parkinson’s Disease: Stimvia Completes Pilot Study and Announces Promising Initial Results
TechRound magazine – June 2024
STIMVIA, a pioneer medical technology company, is introducing an effective non-invasive neuromodulation treatment that offers a way to stimulate deep brain structures without the need for medication or surgery.
CzechCrunch magazine – July 2023
The Czech brain “reprograms” the brain and helps cure diseases.
The Journal of Urology – April 2023
The Journal of Urology – April 2023
Our recent study, led by Jan Krhut and featuring team members Michal Rejchrt, Martin Slovak, Roman V. Dvorak, Lukas Peter, Bertil FM Blok and Peter Zvara, compared the effectiveness of the URIS neuromodulation system and Solifenacin for treating overactive bladder (OAB) has been published in the prestigious journal The Journal of Urology.
Věda a výzkum – November 2022
Czech company comes with unique technology for the treatment of chronic disease.
Czech Industry magazine- 2022
Česká společnost Stimvia vyvinula průlomovou technologii na léčbu nemocí spojených s centrální nervovou soustavou.
Victory in the 4DigitalHealth accelerator – January 2021
The winner of the 4DigitalHealth accelerator is the Czech startup Tesla Medical.